Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

Clinical trial NCT05383482 · COMPLETED

Trial details

NCT number: NCT05383482
Sponsor: Laekna Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor NSCLC Cervical Cancer Endometrial Cancer Esophageal Cancer Gastric and Gastroesophageal Junction Adenocarcinoma

Start date: 2022-07-01
Primary completion: 2024-06-25
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.